The National Brain Tumor Society (NBTS) has a new campaign we strongly support: MyTumorID. #1 of our GBM Bill of Rights is the right to personalized care — biomarker testing of the tumor is key to finding the best possible treatment for that particular individual, everyone is different.

From NBTS:
“With MyTumorID, I decide.

Every brain tumor experience is unique, and every patient deserves a better chance at survival, a better chance at an adequate quality of life, and the best information available to make decisions for their treatment.

With the launch of MyTumorID, the National Brain Tumor Society commits to educating patients and their care partners about the value of biomarker testing and clinical trials, empowering patients to ID their tumor, know their options, and make informed decisions about their treatment. Additionally, we are partnering with providers and other health organizations to increase awareness and access for patients. Together, we can raise awareness about the importance of biomarker testing, demystify the often intimidating prospect of enrolling in a clinical trial, and advance the field of neuro-oncology.”

Learn more at the NBTS website: MyTumorID